Eye Enucleation Clinical Trial
Official title:
Postoperative Pain Control After Enucleation or Evisceration, a Double-Masked Randomized Controlled Trial of Standard Versus Slow-release Bupivacaine
There is a new form of bupivacaine, called Exparel, which can be injected into the eye socket during surgery and may provide pain relief for up to 72 hours. The purpose of the study is to compare the plain bupivacaine injection to Exparel, to see if one medication works better than the other.
During eye removal surgery, bupivacaine is injected, which is a numbing medicine that helps with pain, but it lasts for only 4 to 8 hours. After eye removal, some patients have pain in the eye socket that lasts for several days or up to a week. While this pain can be treated with broad based prescription pain medication, but this may cause side effects, therefore if Exparel reduces the need for additional pain medication, patients may experience better recovery. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00347282 -
Post Enucleation Socket Syndrome Study
|
N/A |